Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.7.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.7.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.7.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.7.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.7.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KW.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KW.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.100 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.100 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.100 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.100 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.100 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.100 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.100 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.100 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.44 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.44 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.44 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.44 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.44 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.44 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.44 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.44 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used